RO5461111
Based on 1 publication(s) in Google Scholar
RO5461111 a highly specific and orally active antagonist of Cathepsin S with IC50s of 0.4 nM (human Cathepsin S) and 0.5 nM (murine Cathepsin S), respectively. RO5461111 can effectively inhibit the activation of antigen-specific T cells and B cells. RO5461111 can improve pulmonary inflammation and lupus nephritis.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 98.01%
- No. CAS: 1252637-46-9
- Fòrmula: C27H24F6N4O4S
- Peso molecular:614.56
-
Almacenamiento:
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Protocolo
- Pureza y Documentación
- Referencias
-
Help & FAQs
-
HY-15533
LY 3000328Cathepsin S Inhibitor -
HY-100231
Cathepsin inhibitor 1Cathepsin Inhibitor -
HY-100350
CA-074 methyl esterCathepsin B Inhibitor -
HY-15100
BalicatibCathepsin K Inhibitor -
HY-N2905
Aurantiamide acetateCathepsin Inhibitor -
HY-115733
Cathepsin L-IN-2Cathepsin L Inhibitor -
HY-118762
KGP94Cathepsin L Inhibitor -
HY-15958
VBY-825Cathepsin Inhibitor -
HY-103352
L-006235Cathepsin K Inhibitor -
HY-146985
Cathepsin X-IN-1Cathepsin X Inhibitor -
HY-100229
AloxistatinCysteine Protease Inhibitor -
HY-17541A
Cysteine Protease inhibitor hydrochlorideCysteine Protease Inhibitor
Publications Citing Use of MedChemExpress (MCE) RO5461111
MoreVer todos los productos específicos de isoformas Cathepsin
More
Actividad biológica
Descripciòn
IC50 & Target
[1]|
human Cathepsin S 0.4 nM (IC50) |
murine Cathepsin S 0.5 nM (IC50) |
In Vitro
RO5461111 (16 h) is cytoactive in cell lines of human (RAJI) or mouse (A20), and significantly reduces splenic dendritic cell activation and subsequent expansion and activation of CD4 T cells and CD4/CD8 double negative T cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
RO5461111 (1.31 mg/mouse or 30 mg/kg; p.o.; 8 weeks) disrupts germinal centres (as CXCL12) and reduces hypergammaglobulinemia and lupus autoantibody production F in MRL-Fas(lpr) mice. And RO5461111 reduces lung inflammation and improves lupus nephritis[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Female MRL-Fas(lpr) mice (12-week-old; with proteinuria/serum creatinine levels up)[1]
-
Dosage:262.5 mg/kg chow; or 5 mg/mouse with 1.31 mg/mouse
-
Administration:Oral gavage; 8 weeks
-
Result:Reduced the activation and expansion of spleen dendritic cells, CD4, double-negative T cells and plasma cells.
Reduced plasma levels of IL-10 and TNF-α.
Chemical Information
-
No. CAS 1252637-46-9
-
Appearance Solid
-
Peso molecular 614.56
-
Fòrmula C27H24F6N4O4S
-
Color White to off-white
-
SMILES
O=C([C@H]1N(C(C2(C(F)(F)F)CC2)=O)C[C@H](S(=O)(C3=CC=C(C4=CC(C)=NC=C4)C=C3C(F)(F)F)=O)C1)NC5(C#N)CC5
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Oncol Rep
2026 Nov;56(5):188. PMID: 42757486
Pureza y Documentación
-
Ficha de datos (276 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
RO5461111 Related Classifications
HY-114374 Related Classifications
Powered by Bioz